Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 110.12 billion as of April 24, 2026. Its market cap has increased by 27.80% in one year.

Market Cap

110.12B

Enterprise Value

17.48B

Revenue

53.13B

Ranking

n/a

PE Ratio

10.88

Stock Price

16,090.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 110.12B, an increase of 688.36%. That is a compound annual growth rate of 9.33%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	110.60B	23.26%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CORESTEMCHEMON	144.17B
BIO-FD&C	123.57B
NovMetaPharma	120.58B
TegoScience	102.80B
KoBioLabs	102.73B
CHA Vaccine Research Institute	96.98B
Quratis	95.42B
CTCBIO	93.12B

Market Cap Rankings